Received Feb 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
COVID after Pfizer COVID shots; COVID after Pfizer COVID shots; needed Paxlovid then, and need Paxlovid now; This is a spontaneous report received from a Consumer or other non HCP, Program ID:. An 82-year-old female patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE NUMBER UNKNOWN), for covid-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID after Pfizer COVID shots"; DISEASE RECURRENCE (medically significant), outcome "unknown", described as "needed Paxlovid then, and need Paxlovid now". Therapeutic measures were taken as a result of drug ineffective, covid-19, disease recurrence. Clinical course: It was reported that about a year ago, patient was at another institution. She needed Paxlovid then and need Paxlovid now as prescribed by her doctor. This happened last time about a year ago. She got the Paxlovid at no charge. She is now in the same position and she need the Paxlovid, and that's why she was calling. She used Pfizer for all her COVID shots. At her age, she do that every 6 months about it. Once before, she used the Paxlovid, and it gave her helped her just have a really mild case of COVID and now she need it again.